DK1381351T3 - Fremgangsmåde til kontinuerlig fremstilling af inhalerbare medikamenter - Google Patents

Fremgangsmåde til kontinuerlig fremstilling af inhalerbare medikamenter

Info

Publication number
DK1381351T3
DK1381351T3 DK02722039T DK02722039T DK1381351T3 DK 1381351 T3 DK1381351 T3 DK 1381351T3 DK 02722039 T DK02722039 T DK 02722039T DK 02722039 T DK02722039 T DK 02722039T DK 1381351 T3 DK1381351 T3 DK 1381351T3
Authority
DK
Denmark
Prior art keywords
continuous preparation
inhalable medications
inhalable
medications
continuous
Prior art date
Application number
DK02722039T
Other languages
Danish (da)
English (en)
Inventor
Bernd Zierenberg
Joerg Schiewe
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7682321&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1381351(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1381351T3 publication Critical patent/DK1381351T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0004—Crystallisation cooling by heat exchange
    • B01D9/0013—Crystallisation cooling by heat exchange by indirect heat exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0036—Crystallisation on to a bed of product crystals; Seeding
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0063—Control or regulation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/30—Injector mixers
    • B01F25/31—Injector mixers in conduits or tubes through which the main component flows
    • B01F25/313—Injector mixers in conduits or tubes through which the main component flows wherein additional components are introduced in the centre of the conduit
    • B01F25/3132—Injector mixers in conduits or tubes through which the main component flows wherein additional components are introduced in the centre of the conduit by using two or more injector devices
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/30—Injector mixers
    • B01F25/31—Injector mixers in conduits or tubes through which the main component flows
    • B01F25/313—Injector mixers in conduits or tubes through which the main component flows wherein additional components are introduced in the centre of the conduit
    • B01F25/3132—Injector mixers in conduits or tubes through which the main component flows wherein additional components are introduced in the centre of the conduit by using two or more injector devices
    • B01F25/31324—Injector mixers in conduits or tubes through which the main component flows wherein additional components are introduced in the centre of the conduit by using two or more injector devices arranged concentrically
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30—Micromixers
    • B01F33/301—Micromixers using specific means for arranging the streams to be mixed, e.g. channel geometries or dispositions
    • B01F33/3012—Interdigital streams, e.g. lamellae
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30—Micromixers
    • B01F33/302—Micromixers the materials to be mixed flowing in the form of droplets
    • B01F33/3021—Micromixers the materials to be mixed flowing in the form of droplets the components to be mixed being combined in a single independent droplet, e.g. these droplets being divided by a non-miscible fluid or consisting of independent droplets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0093—Microreactors, e.g. miniaturised or microfabricated reactors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F2025/91—Direction of flow or arrangement of feed and discharge openings
    • B01F2025/917—Laminar or parallel flow, i.e. every point of the flow moves in layers which do not intermix
    • B01F2025/9171—Parallel flow, i.e. every point of the flow moves in parallel layers where intermixing can occur by diffusion or which do not intermix; Focusing, i.e. compressing parallel layers without intermixing them
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2215/00—Auxiliary or complementary information in relation with mixing
    • B01F2215/04—Technical information in relation with mixing
    • B01F2215/0413—Numerical information
    • B01F2215/0418—Geometrical information
    • B01F2215/0431—Numerical size values, e.g. diameter of a hole or conduit, area, volume, length, width, or ratios thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00781—Aspects relating to microreactors
    • B01J2219/00783—Laminate assemblies, i.e. the reactor comprising a stack of plates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00781—Aspects relating to microreactors
    • B01J2219/00851—Additional features
    • B01J2219/00858—Aspects relating to the size of the reactor
    • B01J2219/0086—Dimensions of the flow channels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00781—Aspects relating to microreactors
    • B01J2219/00873—Heat exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00781—Aspects relating to microreactors
    • B01J2219/00889—Mixing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00781—Aspects relating to microreactors
    • B01J2219/0095—Control aspects
    • B01J2219/00984—Residence time
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/02—Apparatus characterised by their chemically-resistant properties
    • B01J2219/0204—Apparatus characterised by their chemically-resistant properties comprising coatings on the surfaces in direct contact with the reactive components
    • B01J2219/0245—Apparatus characterised by their chemically-resistant properties comprising coatings on the surfaces in direct contact with the reactive components of synthetic organic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Peptides Or Proteins (AREA)
DK02722039T 2001-04-21 2002-01-29 Fremgangsmåde til kontinuerlig fremstilling af inhalerbare medikamenter DK1381351T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10119718A DE10119718A1 (de) 2001-04-21 2001-04-21 Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
PCT/EP2002/000885 WO2002085329A1 (de) 2001-04-21 2002-01-29 Verfahren zur kontinuierlichen herstellung inhalierfähiger arzneistoffe

Publications (1)

Publication Number Publication Date
DK1381351T3 true DK1381351T3 (da) 2004-11-29

Family

ID=7682321

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02722039T DK1381351T3 (da) 2001-04-21 2002-01-29 Fremgangsmåde til kontinuerlig fremstilling af inhalerbare medikamenter

Country Status (12)

Country Link
US (3) US6663848B2 (ja)
EP (2) EP1470814A1 (ja)
JP (1) JP2004528899A (ja)
AR (1) AR033240A1 (ja)
AT (1) ATE279178T1 (ja)
DE (2) DE10119718A1 (ja)
DK (1) DK1381351T3 (ja)
ES (1) ES2231684T3 (ja)
PT (1) PT1381351E (ja)
TR (1) TR200402820T4 (ja)
TW (1) TW559562B (ja)
WO (1) WO2002085329A1 (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
US7718099B2 (en) 2002-04-25 2010-05-18 Tosoh Corporation Fine channel device, fine particle producing method and solvent extraction method
DE10244795A1 (de) * 2002-09-26 2004-04-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
BRPI0506610A (pt) * 2004-02-03 2007-05-02 Chemagis Ltd montelucaste sódico amorfo, processo de preparação de montelucaste sódico amorfo, composição farmacêutica, método de tratamento utilizando a administração de montelucaste sódico amorfo, co-precipitado amorfo de montelucaste sódico e processo de preparação de co-precipitado amorfo de montelucaste sódico
US7934865B2 (en) 2004-02-17 2011-05-03 Ehrfeld Mikrotechnik Bts Gmbh Micromixer
DE102005003965A1 (de) * 2005-01-27 2006-08-10 Ehrfeld Mikrotechnik Gmbh Mikromischer
DE102004012093A1 (de) * 2004-03-05 2005-09-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator mit Merkanaldüse
GB0502398D0 (en) * 2005-02-04 2005-03-16 Q Chip Ltd Device and method for producing spherical segmented flow
DE102004049730B4 (de) * 2004-10-11 2007-05-03 Technische Universität Darmstadt Mikrokapillarreaktor und Verfahren zum kontrollierten Vermengen von nicht homogen mischbaren Fluiden unter Verwendung dieses Mikrokapillarreaktors
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
CA2642577A1 (en) * 2006-02-15 2007-08-23 Tika Lakemedel Ab Methods of manufacturing corticosteroid solutions
US20060223999A1 (en) * 2006-05-10 2006-10-05 Chemagis Ltd. Process for preparing montelukast and precursors thereof
EP2266690A1 (en) * 2006-05-11 2010-12-29 Corning Incorporated High throughput thermally tempered microreactor devices and methods
GB0619442D0 (en) * 2006-10-02 2006-11-08 Q Chip Ltd Beads for use in reactions for the amplification and/or synthesis of a polynucleotide
DE102008037025C5 (de) * 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
US20100294986A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Supercritical fluid facilitated particle formation in microfluidic systems
US20100298602A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Systems and methods for microfluidic crystallization
US8589344B2 (en) * 2009-11-30 2013-11-19 Red Hat, Inc. Systems and methods for generating iterated distributions of data in a hierarchical database
JP5749987B2 (ja) * 2011-06-22 2015-07-15 株式会社神戸製鋼所 液体混合方法及び装置
DE102011078979A1 (de) * 2011-07-11 2013-01-17 Böwe Systec Gmbh Vorrichtung und Verfahren zum Transport einer Hülle
JP5864236B2 (ja) * 2011-12-07 2016-02-17 東芝機械株式会社 マイクロミキサー、マイクロミキサーエレメントおよびその製造方法
JP6006969B2 (ja) * 2012-04-24 2016-10-12 東芝機械株式会社 マイクロミキサー、マイクロミキサーエレメントおよびその製造方法
DE102012221219B4 (de) * 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
US20180161748A1 (en) * 2015-05-29 2018-06-14 Shoei Chemical Inc. Fluid-segmentation device, flow mixing and segmentation device, continuous-flow reactor system, and method for producing nanoparticles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1794084C3 (de) * 1968-09-04 1973-10-25 Union Rheinische Braunkohlen Kraftstoff Ag, 5047 Wesseling Vorrichtung zum kontinuierlichen Gewinnen von Kristallen aus einer Schmelze oder Losung
US5394706A (en) * 1993-05-20 1995-03-07 Waterworks International, Inc. Freeze crystallization for the removal of water from a solution of dissolved solids
WO1998033585A1 (en) * 1997-02-05 1998-08-06 California Institute Of Technology Microfluidic sub-millisecond mixers
US6045703A (en) * 1998-06-15 2000-04-04 Union Carbide Chemicals & Plastics Technology Corporation Separation processes
DE19917156B4 (de) 1999-04-16 2006-01-19 INSTITUT FüR MIKROTECHNIK MAINZ GMBH Verfahren zur Herstellung einer Wasser-in-Dieselöl-Emulsion als Kraftstoff sowie dessen Verwendungen
GB9919693D0 (en) * 1999-08-19 1999-10-20 Rhone Poulenc Rorer Ltd Process
ATE342717T1 (de) * 1999-11-30 2006-11-15 Teva Gyogyszergyar Zartkoeruee Verfahren zur rückgewinnung von statinverbindungen aus einer fermentationsbrühe
DE10005549A1 (de) * 2000-02-09 2001-09-06 Cpc Cellular Process Chemistry Mikroreaktor für Reaktionsmedien in Form einer Suspension
JP4182273B2 (ja) * 2000-06-27 2008-11-19 住友化学株式会社 ε−カプロラクタムの製造方法
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative

Also Published As

Publication number Publication date
TR200402820T4 (tr) 2004-11-22
DE10119718A1 (de) 2002-10-31
ES2231684T3 (es) 2005-05-16
EP1470814A1 (de) 2004-10-27
AR033240A1 (es) 2003-12-10
US20050244314A1 (en) 2005-11-03
ATE279178T1 (de) 2004-10-15
PT1381351E (pt) 2005-02-28
WO2002085329A1 (de) 2002-10-31
US20030175187A1 (en) 2003-09-18
US7249599B2 (en) 2007-07-31
DE50201306D1 (de) 2004-11-18
US7066171B2 (en) 2006-06-27
EP1381351A1 (de) 2004-01-21
EP1381351B1 (de) 2004-10-13
TW559562B (en) 2003-11-01
US20030015194A1 (en) 2003-01-23
JP2004528899A (ja) 2004-09-24
US6663848B2 (en) 2003-12-16

Similar Documents

Publication Publication Date Title
DK1381351T3 (da) Fremgangsmåde til kontinuerlig fremstilling af inhalerbare medikamenter
DK1420759T3 (da) Farmaceutiske sammensætninger til behandling af astma
DK1425001T3 (da) Phenethanolaminderivater til behandling af respiratoriske sygdomme
NO20035426D0 (no) Fremgangsmåte ved administrering av anti-TNF-D-antistoff
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20033143L (no) Farmasoytisk preparat
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
EE200300416A (et) Ravimvorm
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
FI20011889A0 (fi) Menetelmä ksylitolin valmistamiseksi
NO20025805D0 (no) Farmasöytisk preparat
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1446107T3 (da) Fremgangsmåde til fremstilling af tabletter omfattende s-adenosylmethionin
DK1475379T3 (da) Anvendelse af scopinesterderivater til fremstilling af lægemidler
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1353930T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethyliminodieddikesyre
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
NO20035136D0 (no) Fremgangsmåte til fremstilling av imipenem
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater